{name}
{subtitle}
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~18 mi. (Breda, Netherlands, +226 more cities)
facility
Amphia Hospital Location Molengracht ( Site 0474)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
city
~20 mi. (Brasschaat, Belgium, +105 more cities)
facility
AZ Klina ( Site 0106)
drug
bevacizumab, +1 more drug
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~30 mi. (Edegem, Belgium, +147 more cities)
facility
UZA University Hospital Antwerp ( Site 0351)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
city
~30 mi. (Edegem, Belgium, +130 more cities)
facility
UZA University Hospital Antwerp ( Site 0105)
drug
BCG solution, +1 more drug
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~30 mi. (Edegem, Belgium, +199 more cities)
facility
University Hospital Antwerp (UZA) ( Site 0374)